https://prabadinews.com/
  • October 9, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Expert: FDA-Approved Linvoseltamab Delivers Deep Responses, Offering New Hope For Older Patients With MM

Expert: FDA-Approved Linvoseltamab Delivers Deep Responses, Offering New Hope For Older Patients With MM

Sundar Jagannath, MD, MBBS, explains how linvoseltamab showed strong efficacy and tolerability in the LINKER-MM1 trial, making it an appealing option for older patients with relapsed or refractory multiple myeloma (MM).

administrator

Related Articles